4 terminated. 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Terminated 4 |
Follow Atrophy: new trials by email Literature Review of Atrophy trials Research Report on Atrophy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Efficacy and Safety of AVTR101 in Sarcopenic Elderly AVTR101, Placebo - Sarcopenia | Phase 2 | Terminated | Aventi Biotechnology Inc. | 100 | 2022-05-23 | 2025-04-09 |
| Evaluation of FDY-5301 in Major Trauma Patients in ICU FDY-5301, Placebo - ICU Acquired Weakness | Phase 2 | Terminated | Faraday Pharmaceuticals, Inc. | 8 | 2021-09-20 | 2023-06-13 |
| Efficacy and Safety of AXA1665 in Cirrhotic Subjects With Prior Overt Hepatic Encephalopathy AXA1665, Placebo - Hepatic Encephalopathy | Phase 2 | Terminated | Axcella Health, Inc | 12 | 2021-06-29 | 2022-07-27 |
| Efficacy and Safety Study of Tesamorelin in Chronic Obstructive Pulmonary Disease (COPD) Subjects With Muscle Wasting Tesamorelin, Placebo - Chronic Obstructive Pulmonary Disease (COPD) | Phase 2 | Terminated | Theratechnologies | 3 | 2011-09-01 | 2022-03-18 |
Muscular Atrophy (2) · Sarcopenia (2) · Asthenia (1) · End Stage Liver Disease (1) · Hepatic Encephalopathy (1) · Liver Cirrhosis (1) · Pulmonary Disease, Chronic Obstructive (1)
Nervous System Diseases (4) · Neurologic Manifestations (4) · Neuromuscular Manifestations (4) · Pathological Conditions, Anatomical (4) · Pathological Conditions, Signs and Symptoms (4) · Signs and Symptoms (4) · Muscular Atrophy (2) · Pathologic Processes (2) · Brain Diseases (1) · Brain Diseases, Metabolic (1) · Central Nervous System Diseases (1) · Chronic Disease (1) · Digestive System Diseases (1) · Disease Attributes (1)
tesamorelin (1)
Aventi Biotechnology Inc. (1) · Axcella Health, Inc (1) · Faraday Pharmaceuticals, Inc. (1) · Theratechnologies (1)
United States (2) · Canada (1) · Hungary (1) · Italy (1) · Poland (1) · South Korea (1) · Spain (1) · United Kingdom (1)
Andres Duarte-Rojo, M.D. (1) · Richard Casaburi, PhD, MD (1)